MB

MPM BioImpact Portfolio holdings

AUM $577M
1-Year Est. Return 8.33%
This Quarter Est. Return
1 Year Est. Return
+8.33%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$582M
AUM Growth
-$123M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
53
New
Increased
Reduced
Closed

Top Buys

1 +$33.3M
2 +$16.5M
3 +$11.1M
4
UTHR icon
United Therapeutics
UTHR
+$11.1M
5
JANX icon
Janux Therapeutics
JANX
+$9.1M

Top Sells

1 +$26.9M
2 +$24.4M
3 +$22M
4
SRRK icon
Scholar Rock
SRRK
+$18M
5
AKRO icon
Akero Therapeutics
AKRO
+$12.8M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XENE icon
26
Xenon Pharmaceuticals
XENE
$3.21B
$10.2M 1.75%
303,398
+106,186
VERA icon
27
Vera Therapeutics
VERA
$1.99B
$9.99M 1.72%
415,719
+157,931
REPL icon
28
Replimune Group
REPL
$351M
$9.62M 1.65%
987,036
+37,036
IOVA icon
29
Iovance Biotherapeutics
IOVA
$789M
$9.02M 1.55%
2,708,582
+34,677
CNTX icon
30
Context Therapeutics
CNTX
$129M
$9M 1.55%
14,705,882
MBX
31
MBX Biosciences
MBX
$591M
$8.36M 1.44%
+1,132,950
NUVB icon
32
Nuvation Bio
NUVB
$1.17B
$8.19M 1.41%
4,652,243
+488,065
ORIC icon
33
Oric Pharmaceuticals
ORIC
$1.24B
$7.81M 1.34%
+1,399,514
IDYA icon
34
IDEAYA Biosciences
IDYA
$2.56B
$7.05M 1.21%
430,161
+16,126
SLDB icon
35
Solid Biosciences
SLDB
$458M
$6.08M 1.04%
+1,642,356
RLAY icon
36
Relay Therapeutics
RLAY
$1.12B
$6.02M 1.03%
2,295,924
+27,099
STOK icon
37
Stoke Therapeutics
STOK
$1.84B
$4.62M 0.79%
693,988
+8,162
VERU icon
38
Veru
VERU
$60.2M
$3.23M 0.56%
659,273
+230,736
HOWL icon
39
Werewolf Therapeutics
HOWL
$73.2M
$2.34M 0.4%
2,408,810
+20,799
DSGN icon
40
Design Therapeutics
DSGN
$327M
$2.17M 0.37%
562,943
+3,396
ADAP
41
Adaptimmune Therapeutics
ADAP
$53M
$964K 0.17%
4,894,344
-201,568
RPTX icon
42
Repare Therapeutics
RPTX
$78.6M
$808K 0.14%
819,924
-411,230
ALXO icon
43
ALX Oncology
ALXO
$80.3M
$343K 0.06%
550,000
-841,434
AKRO icon
44
Akero Therapeutics
AKRO
$4.32B
-460,617
AQST icon
45
Aquestive Therapeutics
AQST
$856M
-1,611,833
STRO icon
46
Sutro Biopharma
STRO
$85.6M
-2,160,062
ZNTL icon
47
Zentalis Pharmaceuticals
ZNTL
$107M
-1,106,851
ARCT icon
48
Arcturus Therapeutics
ARCT
$561M
-459,943
AXSM icon
49
Axsome Therapeutics
AXSM
$6.38B
-50,000
INSM icon
50
Insmed
INSM
$35B
-389,611